{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:05:37Z","timestamp":1785546337472,"version":"3.56.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,31]]},"DOI":"10.7759\/cureus.113744","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:35:17Z","timestamp":1785540917000},"source":"Crossref","is-referenced-by-count":0,"title":["Nonalcoholic Fatty Liver Disease as a Risk Marker for Incident Type 2 Diabetes Mellitus: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Mudathir Elyas Suleiman","family":"Khamees","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbal Abdalrahman Mohamed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra Bushra","family":"Hassan Babiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayan","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elkhansaa A","family":"Elsamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima Abdelmoneim Yousif","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun H","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, et al.. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022, 183:109119. 10.1016\/j.diabres.2021.109119","journal-title":"Diabetes Res Clin Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01655-5","article-title":"Type 2 diabetes","volume":"400","author":"Ahmad E","year":"2022","unstructured":"Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ. Type 2 diabetes. Lancet. 2022, 400:1803-1820. 10.1016\/S0140-6736(22)01655-5","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi ZM","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023, 77:1335-1347. 10.1097\/HEP.0000000000000004","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng ML","year":"2023","unstructured":"Teng ML, Ng CH, Huang DQ, et al.. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023, 29:S32-S42. 10.3350\/cmh.2022.0365","journal-title":"Clin Mol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella ME","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al.. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023, 79:1542-1556. 10.1016\/j.jhep.2023.06.003","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella ME","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al.. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023, 77:1797-1835. 10.1097\/HEP.0000000000000323","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"European Association for the Study of the Liver (EASL)","year":"2024","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024, 81:492-542. 10.1016\/j.jhep.2024.04.031","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322572","article-title":"Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals","volume":"70","author":"Mantovani A","year":"2021","unstructured":"Mantovani A, Petracca G, Beatrice G, Tilg H, Byrne CD, Targher G. Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. Gut. 2021, 70:962-969. 10.1136\/gutjnl-2020-322572","journal-title":"Gut"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus: mechanisms and treatments","volume":"18","author":"Targher G","year":"2021","unstructured":"Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus: mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021, 18:599-612. 10.1038\/s41575-021-00448-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"European Association for the Study of the Liver (EASL)","year":"2016","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016, 64:1388-1402. 10.1016\/j.jhep.2015.11.004","journal-title":"J Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2022.03.010","article-title":"American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: Co-sponsored by the American Association for the Study of Liver Diseases (AASLD)","volume":"28","author":"Cusi K","year":"2022","unstructured":"Cusi K, Isaacs S, Barb D, et al.. American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: Co-sponsored by the American Association for the Study of Liver Diseases (AASLD). Endocr Pract. 2022, 28:528-562. 10.1016\/j.eprac.2022.03.010","journal-title":"Endocr Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03315-0","article-title":"Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis","volume":"22","author":"Cao L","year":"2024","unstructured":"Cao L, An Y, Liu H, et al.. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis. BMC Med. 2024, 22:101. 10.1186\/s12916-024-03315-0","journal-title":"BMC Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13264","article-title":"Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis","volume":"31","author":"Ballestri S","year":"2016","unstructured":"Ballestri S, Zona S, Targher G, et al.. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016, 31:936-944. 10.1111\/jgh.13264","journal-title":"J Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell M","year":"2020","unstructured":"Campbell M, McKenzie JE, Sowden A, et al.. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020, 368:l6890. 10.1136\/bmj.l6890","journal-title":"BMJ"},{"key":"ref16","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells GA","year":"2026","unstructured":"Wells GA, Shea B, O\u2019Connell D, et al.. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute, Ottawa, ON; 2026."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.67","article-title":"NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study","volume":"104","author":"Adams LA","year":"2009","unstructured":"Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol. 2009, 104:861-867. 10.1038\/ajg.2009.67","journal-title":"Am J Gastroenterol"},{"key":"ref18","article-title":"Establishment and validation of a nomogram that predicts the risk of type 2 diabetes in obese patients with non-alcoholic fatty liver disease: a longitudinal observational study","volume":"14","author":"Cai X","year":"2022","unstructured":"Cai X, Wang M, Liu S, et al.. Establishment and validation of a nomogram that predicts the risk of type 2 diabetes in obese patients with non-alcoholic fatty liver disease: a longitudinal observational study. Am J Transl Res. 2022, 14:4505-4514.","journal-title":"Am J Transl Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5009\/gnl18382","article-title":"Improvement of nonalcoholic fatty liver disease reduces the risk of type 2 diabetes mellitus","volume":"13","author":"Cho HJ","year":"2019","unstructured":"Cho HJ, Hwang S, Park JI, et al.. Improvement of nonalcoholic fatty liver disease reduces the risk of type 2 diabetes mellitus. Gut Liver. 2019, 13:440-449. 10.5009\/gnl18382","journal-title":"Gut Liver"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154866","article-title":"Nonalcoholic fatty liver disease increases the risk of diabetes in young adults: a nationwide population-based study in Korea","volume":"123","author":"Chung GE","year":"2021","unstructured":"Chung GE, Cho EJ, Yoon JW, et al.. Nonalcoholic fatty liver disease increases the risk of diabetes in young adults: a nationwide population-based study in Korea. Metabolism. 2021, 123:154866. 10.1016\/j.metabol.2021.154866","journal-title":"Metabolism"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04781.x","article-title":"Effects of nonalcoholic fatty liver disease on the development of metabolic disorders","volume":"22","author":"Fan JG","year":"2007","unstructured":"Fan JG, Li F, Cai XB, Peng YD, Ao QH, Gao Y. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. J Gastroenterol Hepatol. 2007, 22:1086-1091. 10.1111\/j.1440-1746.2006.04781.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12912","article-title":"The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals","volume":"36","author":"Fukuda T","year":"2016","unstructured":"Fukuda T, Hamaguchi M, Kojima T, et al.. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals. Liver Int. 2016, 36:275-283. 10.1111\/liv.12912","journal-title":"Liver Int"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2020.111080","article-title":"Development and course of diabetes according to genetic factors and diabetes treatment among patients with nonalcoholic fatty liver disease","volume":"83","author":"Kogiso T","year":"2021","unstructured":"Kogiso T, Sagawa T, Kodama K, Taniai M, Hashimoto E, Tokushige K. Development and course of diabetes according to genetic factors and diabetes treatment among patients with nonalcoholic fatty liver disease. Nutrition. 2021, 83:111080. 10.1016\/j.nut.2020.111080","journal-title":"Nutrition"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32560","article-title":"NAFLD improves risk prediction of type 2 diabetes: with effect modification by sex and menopausal status","volume":"76","author":"Kim Y","year":"2022","unstructured":"Kim Y, Chang Y, Ryu S, Wild SH, Byrne CD. NAFLD improves risk prediction of type 2 diabetes: with effect modification by sex and menopausal status. Hepatology. 2022, 76:1755-1765. 10.1002\/hep.32560","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.680664","article-title":"The risk of type 2 diabetes and coronary artery disease in non-obese patients with non-alcoholic fatty liver disease: a cohort study","volume":"8","author":"Dai W","year":"2021","unstructured":"Dai W, Zhang Z, Zhao S. The risk of type 2 diabetes and coronary artery disease in non-obese patients with non-alcoholic fatty liver disease: a cohort study. Front Cardiovasc Med. 2021, 8:680664. 10.3389\/fcvm.2021.680664","journal-title":"Front Cardiovasc Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-054891","article-title":"Clinical outcome of non-alcoholic fatty liver disease: an 11-year follow-up study","volume":"12","author":"Tang X","year":"2022","unstructured":"Tang X, Shi Y, Du J, et al.. Clinical outcome of non-alcoholic fatty liver disease: an 11-year follow-up study. BMJ Open. 2022, 12:e054891. 10.1136\/bmjopen-2021-054891","journal-title":"BMJ Open"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15877","article-title":"Non-alcoholic fatty liver disease, sleep behaviors, and incident type 2 diabetes","volume":"37","author":"Zhang H","year":"2022","unstructured":"Zhang H, Wang Y, Chen C, et al.. Non-alcoholic fatty liver disease, sleep behaviors, and incident type 2 diabetes. J Gastroenterol Hepatol. 2022, 37:1633-1640. 10.1111\/jgh.15877","journal-title":"J Gastroenterol Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-009-0091-1","article-title":"Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease","volume":"44","author":"Arase Y","year":"2009","unstructured":"Arase Y, Suzuki F, Ikeda K, Kumada H, Tsuji H, Kobayashi T. Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease. J Gastroenterol. 2009, 44:1064-1070. 10.1007\/s00535-009-0091-1","journal-title":"J Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal AJ","year":"2021","unstructured":"Sanyal AJ, Van Natta ML, Clark J, et al.. Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N Engl J Med. 2021, 385:1559-1569. 10.1056\/NEJMoa2029349","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i32.9607","article-title":"Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus","volume":"21","author":"Li WD","year":"2015","unstructured":"Li WD, Fu KF, Li GM, Lian YS, Ren AM, Chen YJ, Xia JR. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus. World J Gastroenterol. 2015, 21:9607-9613. 10.3748\/wjg.v21.i32.9607","journal-title":"World J Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1055\/a-1813-7435","article-title":"Cigarette smoking increases the risk of type 2 diabetes mellitus in patients with non-alcoholic fatty liver disease: a population-based cohort study","volume":"130","author":"Liu C","year":"2022","unstructured":"Liu C, Wu Y, Duan W, Xu W. Cigarette smoking increases the risk of type 2 diabetes mellitus in patients with non-alcoholic fatty liver disease: a population-based cohort study. Exp Clin Endocrinol Diabetes. 2022, 130:793-800. 10.1055\/a-1813-7435","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14414","article-title":"The amount of liver fat predicts mortality and development of type 2 diabetes in non-alcoholic fatty liver disease","volume":"40","author":"Nasr P","year":"2020","unstructured":"Nasr P, Fredrikson M, Ekstedt M, Kechagias S. The amount of liver fat predicts mortality and development of type 2 diabetes in non-alcoholic fatty liver disease. Liver Int. 2020, 40:1069-1078. 10.1111\/liv.14414","journal-title":"Liver Int"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13428","article-title":"Adherence to a vegetable dietary pattern attenuates the risk of non-alcoholic fatty liver disease in incident type 2 diabetes: the TCLSIH cohort study","volume":"291","author":"Xia Y","year":"2022","unstructured":"Xia Y, Cao L, Zhang Q, et al.. Adherence to a vegetable dietary pattern attenuates the risk of non-alcoholic fatty liver disease in incident type 2 diabetes: the TCLSIH cohort study. J Intern Med. 2022, 291:469-480. 10.1111\/joim.13428","journal-title":"J Intern Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2017.10.019","article-title":"The persistence of fatty liver has a differential impact on the development of diabetes: the Kangbuk Samsung Health Study","volume":"135","author":"Bae JC","year":"2018","unstructured":"Bae JC, Han JM, Cho JH, et al.. The persistence of fatty liver has a differential impact on the development of diabetes: the Kangbuk Samsung Health Study. Diabetes Res Clin Pract. 2018, 135:1-6. 10.1016\/j.diabres.2017.10.019","journal-title":"Diabetes Res Clin Pract"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.56.7115","article-title":"Non-alcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men and women","volume":"56","author":"Tokita Y","year":"2017","unstructured":"Tokita Y, Maejima Y, Shimomura K, et al.. Non-alcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men and women. Intern Med. 2017, 56:763-771. 10.2169\/internalmedicine.56.7115","journal-title":"Intern Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-021-01485-x","article-title":"Association between nonalcoholic fatty liver disease and incident diabetes mellitus among Japanese: a retrospective cohort study using propensity score matching","volume":"20","author":"Zheng X","year":"2021","unstructured":"Zheng X, Cao C, He Y, Wang X, Wu J, Hu H. Association between nonalcoholic fatty liver disease and incident diabetes mellitus among Japanese: a retrospective cohort study using propensity score matching. Lipids Health Dis. 2021, 20:59. 10.1186\/s12944-021-01485-x","journal-title":"Lipids Health Dis"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53947-z","article-title":"The impact of NAFLD and waist circumference changes on diabetes development in prediabetes subjects","volume":"9","author":"Lee J","year":"2019","unstructured":"Lee J, Cho YK, Kang YM, et al.. The impact of NAFLD and waist circumference changes on diabetes development in prediabetes subjects. Sci Rep. 2019, 9:17258. 10.1038\/s41598-019-53947-z","journal-title":"Sci Rep"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0143","article-title":"Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study","volume":"181","author":"Sinn DH","year":"2019","unstructured":"Sinn DH, Kang D, Cho SJ, Paik SW, Guallar E, Cho J, Gwak GY. Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study. Eur J Endocrinol. 2019, 181:185-192. 10.1530\/EJE-19-0143","journal-title":"Eur J Endocrinol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12851","article-title":"Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study","volume":"35","author":"Ming J","year":"2015","unstructured":"Ming J, Xu S, Gao B, et al.. Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study. Liver Int. 2015, 35:2401-2417. 10.1111\/liv.12851","journal-title":"Liver Int"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/nu16213788","article-title":"Protective effect of high adherence to Mediterranean diet on the risk of incident type-2 diabetes in subjects with MAFLD: the Di@bet.es Study","volume":"16","author":"Lago-Sampedro A","year":"2024","unstructured":"Lago-Sampedro A, Oualla-Bachiri W, Garc\u00eda-Serrano S, et al.. Protective effect of high adherence to Mediterranean diet on the risk of incident type-2 diabetes in subjects with MAFLD: the Di@bet.es Study. Nutrients. 2024, 16:3788. 10.3390\/nu16213788","journal-title":"Nutrients"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15661","article-title":"Nonalcoholic fatty liver disease without overlapping metabolic-associated fatty liver disease and the risk of incident type 2 diabetes","volume":"43","author":"Cho Y","year":"2023","unstructured":"Cho Y, Chang Y, Ryu S, Wild SH, Byrne CD. Nonalcoholic fatty liver disease without overlapping metabolic-associated fatty liver disease and the risk of incident type 2 diabetes. Liver Int. 2023, 43:2445-2454. 10.1111\/liv.15661","journal-title":"Liver Int"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1108442","article-title":"The change of non-alcoholic fatty liver disease is associated with risk of incident diabetes","volume":"14","author":"Chen C","year":"2023","unstructured":"Chen C, Zhang Y, Fan Y, Ying Z, Su Q, Li X, Qin L. The change of non-alcoholic fatty liver disease is associated with risk of incident diabetes. Front Endocrinol (Lausanne). 2023, 14:1108442. 10.3389\/fendo.2023.1108442","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1590\/0102-311XEN009924","article-title":"Comparing diabetes prediction based on metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease: the ELSA-Brasil study","volume":"40","author":"Lopes GW","year":"2024","unstructured":"Lopes GW, Canhada SL, Reis RC, et al.. Comparing diabetes prediction based on metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease: the ELSA-Brasil study. Cad Saude Publica. 2024, 40:e00009924. 10.1590\/0102-311XEN009924","journal-title":"Cad Saude Publica"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0327058","article-title":"Fatty liver index and risk of type 2 diabetes of adults with normoglycemia: insights into insulin sensitivity and beta-cell function","volume":"20","author":"Bae JH","year":"2025","unstructured":"Bae JH, Lee MJ, Kim SH, Kim JY, Khang AR, Kang YH, Yi D. Fatty liver index and risk of type 2 diabetes of adults with normoglycemia: insights into insulin sensitivity and beta-cell function. PLoS One. 2025, 20:e0327058. 10.1371\/journal.pone.0327058","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-024-01435-4","article-title":"Risk of incident type 2 diabetes in male NAFLD and NAFLD-free smokers: a 7-year post-cessation study","volume":"16","author":"Xie J","year":"2024","unstructured":"Xie J, Lin P, Hou L, et al.. Risk of incident type 2 diabetes in male NAFLD and NAFLD-free smokers: a 7-year post-cessation study. Diabetol Metab Syndr. 2024, 16:192. 10.1186\/s13098-024-01435-4","journal-title":"Diabetol Metab Syndr"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2023.108475","article-title":"Indices of hepatic steatosis and fibrosis in prediabetes and association with diabetes development in the vitamin D and type 2 diabetes study","volume":"37","author":"Corbin KD","year":"2023","unstructured":"Corbin KD, Pittas AG, Desouza C, et al.. Indices of hepatic steatosis and fibrosis in prediabetes and association with diabetes development in the vitamin D and type 2 diabetes study. J Diabetes Compl. 2023, 37:108475. 10.1016\/j.jdiacomp.2023.108475","journal-title":"J Diabetes Compl"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.14315","article-title":"Metabolic dysfunction-associated steatotic liver disease: a superior predictor for incident type 2 diabetes over traditional criteria - NAGALA study","volume":"15","author":"Sakai K","year":"2024","unstructured":"Sakai K, Okamura T, Toyokuni E, et al.. Metabolic dysfunction-associated steatotic liver disease: a superior predictor for incident type 2 diabetes over traditional criteria - NAGALA study. J Diabetes Investig. 2024, 15:1788-1796. 10.1111\/jdi.14315","journal-title":"J Diabetes Investig"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1173757","article-title":"Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period","volume":"14","author":"Li N","year":"2023","unstructured":"Li N, Xang W, Wu S, et al.. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period. Front Endocrinol (Lausanne). 2023, 14:1173757. 10.3389\/fendo.2023.1173757","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S462459","article-title":"Association between the hepatic steatosis index and risk of incident type 2 diabetes mellitus in the normoglycemic population: a longitudinal prospective study in Japan","volume":"17","author":"Si R","year":"2024","unstructured":"Si R, Xiao J, Zheng K, Yin Y, Li Y. Association between the hepatic steatosis index and risk of incident type 2 diabetes mellitus in the normoglycemic population: a longitudinal prospective study in Japan. Diabetes Metab Syndr Obes. 2024, 17:2317-2326. 10.2147\/DMSO.S462459","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-37858-8","article-title":"Increased risk of incident diabetes in patients with MAFLD not meeting the criteria for NAFLD","volume":"13","author":"Park SH","year":"2023","unstructured":"Park SH, Park J, Kwon SY, et al.. Increased risk of incident diabetes in patients with MAFLD not meeting the criteria for NAFLD. Sci Rep. 2023, 13:10677. 10.1038\/s41598-023-37858-8","journal-title":"Sci Rep"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad433","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis with liver fibrosis as predictors of new-onset diabetes mellitus in people with HIV: a longitudinal cohort study","volume":"77","author":"Han WM","year":"2023","unstructured":"Han WM, Apornpong T, Lwin HM, et al.. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis with liver fibrosis as predictors of new-onset diabetes mellitus in people with HIV: a longitudinal cohort study. Clin Infect Dis. 2023, 77:1687-1695. 10.1093\/cid\/ciad433","journal-title":"Clin Infect Dis"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-025-02518-5","article-title":"Non-linear relationship between triglyceride glucose index and new-onset diabetes among individuals with non-alcoholic fatty liver disease: a cohort study","volume":"24","author":"Liang X","year":"2025","unstructured":"Liang X, Lai K, Li X, Li Y, Xing Z, Gui S. Non-linear relationship between triglyceride glucose index and new-onset diabetes among individuals with non-alcoholic fatty liver disease: a cohort study. Lipids Health Dis. 2025, 24:94. 10.1186\/s12944-025-02518-5","journal-title":"Lipids Health Dis"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.83371","article-title":"U-shaped association between triglyceride and risk of incident diabetes in normoglycemic males with NAFLD: a population-base cohort study","volume":"20","author":"Xie X","year":"2023","unstructured":"Xie X, Liao J, Huang C, et al.. U-shaped association between triglyceride and risk of incident diabetes in normoglycemic males with NAFLD: a population-base cohort study. Int J Med Sci. 2023, 20:1417-1424. 10.7150\/ijms.83371","journal-title":"Int J Med Sci"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-023-01016-1","article-title":"Synergistic effect of non-alcoholic fatty liver disease and history of gestational diabetes to increase risk of type 2 diabetes","volume":"38","author":"Cho Y","year":"2023","unstructured":"Cho Y, Chang Y, Ryu S, Wild SH, Byrne CD. Synergistic effect of non-alcoholic fatty liver disease and history of gestational diabetes to increase risk of type 2 diabetes. Eur J Epidemiol. 2023, 38:901-911. 10.1007\/s10654-023-01016-1","journal-title":"Eur J Epidemiol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-023-05903-w","article-title":"Racial difference in the association between non-alcoholic fatty liver disease and incident type 2 diabetes: findings from the CARDIA study","volume":"66","author":"Hatano Y","year":"2023","unstructured":"Hatano Y, VanWagner LB, Carnethon MR, et al.. Racial difference in the association between non-alcoholic fatty liver disease and incident type 2 diabetes: findings from the CARDIA study. Diabetologia. 2023, 66:1235-1246. 10.1007\/s00125-023-05903-w","journal-title":"Diabetologia"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13030503","article-title":"Association of Fatty Liver Index with Incident Diabetes Risk in Patients Initiating Statin-Therapy: A 6-Year Retrospective Study","volume":"13","author":"Anastasiou G","year":"2023","unstructured":"Anastasiou G, Liberopoulos E, Petkou E, et al.. Association of Fatty Liver Index with Incident Diabetes Risk in Patients Initiating Statin-Therapy: A 6-Year Retrospective Study. Diagnostics (Basel). 2023, 13:503. 10.3390\/diagnostics13030503","journal-title":"Diagnostics (Basel)"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3390\/nu15030792","article-title":"Lifestyle intervention in NAFLD: long-term diabetes incidence in subjects treated by web- and group-based programs","volume":"15","author":"Petroni ML","year":"2023","unstructured":"Petroni ML, Brodosi L, Armandi A, Marchignoli F, Bugianesi E, Marchesini G. Lifestyle intervention in NAFLD: long-term diabetes incidence in subjects treated by web- and group-based programs. Nutrients. 2023, 15:792. 10.3390\/nu15030792","journal-title":"Nutrients"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1590\/0102-311XEN090522","article-title":"Liver steatosis as a predictor of incident diabetes in adults: a prospective evaluation in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)","volume":"39","author":"Faria LC","year":"2023","unstructured":"Faria LC, Diniz MF, Giatti L, Schmidt MI, Goulart AC, Duncan BB, Barreto SM. Liver steatosis as a predictor of incident diabetes in adults: a prospective evaluation in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Cad Saude Publica. 2023, 39:e00090522. 10.1590\/0102-311XEN090522","journal-title":"Cad Saude Publica"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0288820","article-title":"Regression of nonalcoholic fatty liver disease is associated with reduced risk of incident diabetes: A longitudinal cohort study","volume":"18","author":"Sinn DH","year":"2023","unstructured":"Sinn DH, Kang D, Guallar E, et al.. Regression of nonalcoholic fatty liver disease is associated with reduced risk of incident diabetes: A longitudinal cohort study. PLoS One. 2023, 18:e0288820. 10.1371\/journal.pone.0288820","journal-title":"PLoS One"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-023-10576-z","article-title":"Severity of fatty liver is highly correlated with the risk of hypertension and diabetes: a cross-sectional and longitudinal cohort study","volume":"18","author":"Shih CI","year":"2024","unstructured":"Shih CI, Wu KT, Hsieh MH, et al.. Severity of fatty liver is highly correlated with the risk of hypertension and diabetes: a cross-sectional and longitudinal cohort study. Hepatol Int. 2024, 18:138-154. 10.1007\/s12072-023-10576-z","journal-title":"Hepatol Int"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2023.11.021","article-title":"Changes in Fatty Liver Disease and Incident Diabetes Mellitus in Young Korean Adults","volume":"66","author":"Park KY","year":"2024","unstructured":"Park KY, Hwang HS, Han K, Park HK. Changes in Fatty Liver Disease and Incident Diabetes Mellitus in Young Korean Adults. Am J Prev Med. 2024, 66:717-724. 10.1016\/j.amepre.2023.11.021","journal-title":"Am J Prev Med"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111584","article-title":"Metabolic dysfunction-associated fatty liver disease increases the risk of type 2 diabetes mellitus in young Korean adults","volume":"212","author":"Ha J","year":"2024","unstructured":"Ha J, Hong OK, Han K, Kwon HS. Metabolic dysfunction-associated fatty liver disease increases the risk of type 2 diabetes mellitus in young Korean adults. Diabetes Res Clin Pract. 2024, 212:111584. 10.1016\/j.diabres.2024.111584","journal-title":"Diabetes Res Clin Pract"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S446042","article-title":"ZJU index as a predictive tool for diabetes incidence: insights from a population-based cohort study","volume":"17","author":"Wu C","year":"2024","unstructured":"Wu C, Loh YH, Huang H, Xu C. ZJU index as a predictive tool for diabetes incidence: insights from a population-based cohort study. Diabetes Metab Syndr Obes. 2024, 17:715-724. 10.2147\/DMSO.S446042","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1465032","article-title":"Predicting incident type 2 diabetes in a Japanese cohort: an 8-year analysis of the NAGALA database","volume":"16","author":"Wang Y","year":"2025","unstructured":"Wang Y, Liu F, Tong R, et al.. Predicting incident type 2 diabetes in a Japanese cohort: an 8-year analysis of the NAGALA database. Front Endocrinol (Lausanne). 2025, 16:1465032. 10.3389\/fendo.2025.1465032","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-025-02046-4","article-title":"Association between AIP and incident T2DM in patients with NAFLD: a retrospective study","volume":"25","author":"Chen Y","year":"2025","unstructured":"Chen Y, Bai Q, Hua H. Association between AIP and incident T2DM in patients with NAFLD: a retrospective study. BMC Endocr Disord. 2025, 25:221. 10.1186\/s12902-025-02046-4","journal-title":"BMC Endocr Disord"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01828-z","article-title":"Remnant cholesterol predicts the development of type 2 diabetes in patients with nonalcoholic fatty liver disease","volume":"17","author":"Yang L","year":"2025","unstructured":"Yang L, Huang H, Wang Z, Xu C. Remnant cholesterol predicts the development of type 2 diabetes in patients with nonalcoholic fatty liver disease. Diabetol Metab Syndr. 2025, 17:277. 10.1186\/s13098-025-01828-z","journal-title":"Diabetol Metab Syndr"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1594548","article-title":"Study on the correlation between triglyceride glucose index, triglyceride glucose index to high-density lipoprotein cholesterol ratio, and the risk of diabetes in nonalcoholic fatty liver disease","volume":"16","author":"Sun T","year":"2025","unstructured":"Sun T, Liu J. Study on the correlation between triglyceride glucose index, triglyceride glucose index to high-density lipoprotein cholesterol ratio, and the risk of diabetes in nonalcoholic fatty liver disease. Front Endocrinol (Lausanne). 2025, 16:1594548. 10.3389\/fendo.2025.1594548","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1516187","article-title":"U-shaped relationship between the triglyceride glucose index and the risk of incident diabetes among MASLD adults: a retrospective cohort study","volume":"16","author":"Cao C","year":"2025","unstructured":"Cao C, Zhang X, Han Y, Hu H, Wang Y. U-shaped relationship between the triglyceride glucose index and the risk of incident diabetes among MASLD adults: a retrospective cohort study. Front Endocrinol (Lausanne). 2025, 16:1516187. 10.3389\/fendo.2025.1516187","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-024-01828-6","article-title":"Cardiac metabolic index as a predictor of new-onset diabetes in non-alcoholic fatty liver disease patients: a longitudinal cohort analysis","volume":"25","author":"Hou S","year":"2025","unstructured":"Hou S, Wang Y, Wei Z, et al.. Cardiac metabolic index as a predictor of new-onset diabetes in non-alcoholic fatty liver disease patients: a longitudinal cohort analysis. BMC Endocr Disord. 2025, 25:13. 10.1186\/s12902-024-01828-6","journal-title":"BMC Endocr Disord"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000002943","article-title":"Cardiovascular events and incident diabetes in 220 patients with MASLD according to basal liver fibrosis: a 10-year follow-up historic cohort","volume":"37","author":"Choque Vargas C","year":"2025","unstructured":"Choque Vargas C, C\u00e1ceres F, Landeira G, et al.. Cardiovascular events and incident diabetes in 220 patients with MASLD according to basal liver fibrosis: a 10-year follow-up historic cohort. Eur J Gastroenterol Hepatol. 2025, 37:660-667. 10.1097\/MEG.0000000000002943","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.70077","article-title":"Dynamics of cardiometabolic risk factors are linked to the risk of hypertension and diabetes in MASLD","volume":"41","author":"Shih CI","year":"2025","unstructured":"Shih CI, Yeh ML, Lin YH, et al.. Dynamics of cardiometabolic risk factors are linked to the risk of hypertension and diabetes in MASLD. Kaohsiung J Med Sci. 2025, 41:e70077. 10.1002\/kjm2.70077","journal-title":"Kaohsiung J Med Sci"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02953-9","article-title":"The role of insulin resistance in the longitudinal progression from NAFLD to cardiovascular-kidney-metabolic disease","volume":"24","author":"Hou C","year":"2025","unstructured":"Hou C, Yuan X, Peng M, et al.. The role of insulin resistance in the longitudinal progression from NAFLD to cardiovascular-kidney-metabolic disease. Cardiovasc Diabetol. 2025, 24:398. 10.1186\/s12933-025-02953-9","journal-title":"Cardiovasc Diabetol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101645","article-title":"Validation of a data-driven clustering model for MASLD: Evidence from three large-scale Asian cohorts","volume":"8","author":"Zhou XD","year":"2026","unstructured":"Zhou XD, Song SJ, Guo CY, et al.. Validation of a data-driven clustering model for MASLD: Evidence from three large-scale Asian cohorts. JHEP Rep. 2026, 8:101645. 10.1016\/j.jhepr.2025.101645","journal-title":"JHEP Rep"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70381","article-title":"Associations between steatotic liver disease subtypes and incident diabetes in young Korean adults: A nationwide cohort study","volume":"28","author":"Chung GE","year":"2026","unstructured":"Chung GE, Yu SJ, Park J, Kim YJ, Yoon JH, Han K, Cho EJ. Associations between steatotic liver disease subtypes and incident diabetes in young Korean adults: A nationwide cohort study. Diabetes Obes Metab. 2026, 28:1947-1955. 10.1111\/dom.70381","journal-title":"Diabetes Obes Metab"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2026.06.028","article-title":"Association of metabolic dysfunction-associated steatotic liver disease onset age with risk of incident type 2 diabetes","author":"Huo Z","year":"2026","unstructured":"Huo Z, Li Y, Liu T, et al.. Association of metabolic dysfunction-associated steatotic liver disease onset age with risk of incident type 2 diabetes. Clin Gastroenterol Hepatol. 2026, 10.1016\/j.cgh.2026.06.028","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2026.1805902","article-title":"TyG-WHtR predicts incident type 2 diabetes mellitus in NAFLD: a 12-year prospective cohort study","volume":"17","author":"Chen N","year":"2026","unstructured":"Chen N, Li J, Li G, Zhao F. TyG-WHtR predicts incident type 2 diabetes mellitus in NAFLD: a 12-year prospective cohort study. Front Endocrinol (Lausanne). 2026, 17:1805902. 10.3389\/fendo.2026.1805902","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0350633","article-title":"Association between the triglyceride-glycated hemoglobin index and diabetes risk among patients with Non-alcoholic fatty liver disease: A longitudinal cohort study","volume":"21","author":"Wei C","year":"2026","unstructured":"Wei C, Cao C, Xu Z, et al.. Association between the triglyceride-glycated hemoglobin index and diabetes risk among patients with Non-alcoholic fatty liver disease: A longitudinal cohort study. PLoS One. 2026, 21:e0350633. 10.1371\/journal.pone.0350633","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/489446-nonalcoholic-fatty-liver-disease-as-a-risk-marker-for-incident-type-2-diabetes-mellitus-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:35:18Z","timestamp":1785540918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/489446-nonalcoholic-fatty-liver-disease-as-a-risk-marker-for-incident-type-2-diabetes-mellitus-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":77,"URL":"https:\/\/doi.org\/10.7759\/cureus.113744","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,31]]}}}